← Open Payments lookup

NPI 1588066021: Open Payments

NPI 1588066021. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$363 in 24 payments from 11 companies in 2025. Trend: 2023 $341 · 2024 $336 · 2025 $363

Food & beverage: $363
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.2$54
Abbott Laboratories3$49
SANOFI-AVENTIS U.S. LLC2$38
Exact Sciences Corporation2$38
Novo Nordisk Inc2$37
Avvisto Therapeutics, LLC2$34
Lilly USA, LLC2$33
Astellas Pharma US Inc2$28
IBSA Pharma Inc.1$21
AstraZeneca Pharmaceuticals LP1$16

Products named: JARDIANCE, FREESTYLE LIBRE, TZIELD, Rybelsus, CYCLOSET, Veozah, Tirosint, The Cologuard Plus Collection Kit.